Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
LAS VEGAS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Miracle Flights, previously known as "Miracle Flights for Kids" or "Angel Planes," is seeking to reconnect with patients and families that flew with the organization prior to 2011.
The organization hopes to connect for the purpose of obtaining updates on past flight recipients, including current medical status, major life events, education, career, hobbies, passions, etc. Updated stories may be utilized as testimonials and/or for an upcoming PBS special on Miracle Flights. Recording will take place at the Miracle Flights headquarters in March, and some recipients may be asked to participate in the project. Former patients not interested in appearing publically are still encouraged to submit an update for archival purposes.
Those interested in connecting are encouraged to contact:
Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
CONTACT: Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
